Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 15 April 1983:
Vol. 220. no. 4594, pp. 325 - 327
DOI: 10.1126/science.6836275

Articles

Science, Vol 220, Issue 4594, 325-327
Copyright © 1983 by American Association for the Advancement of Science


articles

Digoxin-inactivating bacteria: identification in human gut flora

Saha JR, VP Butler Jr, HC Neu, and J Lindenbaum

Digoxin, the most widely used cardiac glycoside, undergoes significant metabolic conversion in many patients to cardioinactive metabolites in which the lactone ring is reduced. This appears to occur within the gastrointestinal tract. An attempt was made to isolate and identify the organisms capable of reducing digoxin from stool cultures obtained from human volunteers. Of hundreds of isolates studied, only Eubacterium lentum, a common anaerobe of the human colonic flora, converted digoxin to reduced derivatives. Such organisms were also isolated in high concentrations from the stools of individuals who did not excrete these metabolites when given digoxin in vivo. When the growth of E. lentum was stimulated by arginine, inactivation of digoxin was inhibited. Neither the presence of these organisms alone nor their concentration within the gut flora appeared to determine whether digoxin would be inactivated by this pathway in vivo.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A prospective study of the clarithromycin-digoxin interaction in elderly patients.
P. Zapater, S. Reus, A. Tello, D. Torrus, M. Perez-Mateo, and J. F. Horga (2002)
J. Antimicrob. Chemother. 50, 601-606
   Abstract »    Full Text »    PDF »
Secretion of a Lactone-Hydrogenated Ouabain-Like Effector of Sodium, Potassium-Adenosine Triphosphatase Activity by Adrenal Cells.
H. M. A. M. Qazzaz, M. A. El-Masri, and R. Valdes Jr. (2000)
Endocrinology 141, 3200-3209
   Abstract »    Full Text »    PDF »
Deglycosylated Products of Endogenous Digoxin-like Immunoreactive Factor in Mammalian Tissue.
H. M. A. M. Qazzaz, S. L. Goudy, and R. Valdes Jr. (1996)
J. Biol. Chem. 271, 8731-8737
   Abstract »    Full Text »    PDF »
Lack of Acipimox-Digoxin Interaction in Patient Volunteers.
C. P. Chijioke, R. M. Pearson, and S. Benedetti (1992)
Human and Experimental Toxicology 11, 357-359
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)